Watchlist Price Alert

Spyre Therapeutics Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

17.23

-0.06 (-0.35%)

At close: Jun 16, 2025, 3:59 PM

17.60

2.15%

Pre-market: Jun 17, 2025, 05:28 AM EDT

-0.35% (1D)

Bid	12.48
Market Cap	1.04B
Revenue (ttm)	n/a
Net Income (ttm)	-208.93M
EPS (ttm)	-3.06
PE Ratio (ttm)	-5.63
Forward PE	-5.25
Analyst	Buy

Ask	21.74
Volume	317,885
Avg. Volume (20D)	625,274
Open	17.51
Previous Close	17.29
Day's Range	16.74 - 18.01
52-Week Range	10.91 - 40.26
Beta	2.73

About SYRE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SYRE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SYRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 day ago New

-0.64%

Spyre Therapeutics shares are trading higher after... Unlock content with Pro Subscription

1 month ago

+9.64%

Spyre Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS results.

News

2 weeks ago · zacks.com

Wall Street Analysts Predict a 244.05% Upside in Spyre Therapeutics (SYRE): Here's What You Should Know

The mean of analysts' price targets for Spyre Therapeutics (SYRE) points to a 244.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement am...

1 month ago · zacks.com

How Much Upside is Left in Spyre Therapeutics (SYRE)? Wall Street Analysts Think 258.34%

The average of price targets set by Wall Street analysts indicates a potential upside of 258.3% in Spyre Therapeutics (SYRE). While the effectiveness of this highly sought-after metric is questionable...